Articles tagged with Lung Cancer
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
The Tobacco Atlas estimates that tobacco use kills six million people annually, with two million cancer deaths projected by 2015. The global economy loses $500 billion due to tobacco use, mainly in low- and middle-income countries.
A recent study published in the Journal of Thoracic Oncology found that tumor size and level of visceral pleura invasion significantly impact the survival of non-small cell lung cancer (NSCLC) patients. Researchers analyzed data from over 9,700 surgical resection cases and divided patients into nine groups based on tumor size and VPI.
Researchers at the University of Pittsburgh School of Medicine have discovered a protein called cyclin B1 that is made in excess levels in many cancers. A vaccine targeting this protein may prevent malignancies in high-risk individuals, with promising results in mice vaccinated against it. The study's findings suggest that natural immu...
A Montreal study links heavy consumption of beer and spirits to an increased risk of six different cancers, including oesophageal, colon, lung, pancreatic, liver, and prostate cancer. Heavy drinkers face a sevenfold increased risk of esophageal cancer and an 80% higher risk of colon cancer.
Researchers found that combination therapies tailored to patient prognosis improved patient outcomes and increased five-year, disease-free survival rates. Prophylactic cranial irradiation was shown to significantly decrease the risk for brain metastases in NSCLC patients.
Studies presented at the WCLC confirm that targeted therapies have improved efficacy and prolonged progression-free survival time compared to chemotherapy. Patients with EGFR mutations who received gefitinib experienced longer progression-free survival and greater objective response rates, while erlotinib showed prolonged progression-f...
A combination of bevacizumab and erlotinib appears to be effective in treating non-small cell lung cancer (NSCLC) in elderly patients, with four partial responses observed. The regimen is well-tolerated, with common side effects including high blood pressure, fatigue, and diarrhea.
Researchers at Fox Chase Cancer Center have found that lung cancer patients who have progressed on a cetuximab-containing regimen may respond to erlotinib. The study suggests that patients who are no longer controlled by cetuximab can derive clinical benefit from erlotinib, offering an additional treatment option.
Researchers found that patients with second primary lung cancers (SPLC) are more likely to receive surgical treatment and have localized disease at diagnosis compared to those with one primary lung cancer (OPLC). However, SPLC patients experience a 12% higher lung cancer-specific mortality rate.
Fox Chase researchers found that DLX5 promotes cancer by activating the expression of MYC, a potent factor in numerous cancers. The discovery suggests that DLX5 could be an ideal target for future anti-cancer drugs.
Researchers at Ohio State University Comprehensive Cancer Center identified a molecule, miR-21, playing an early and important role in the development of nonsmoking lung cancer. The study found that miR-21 levels were high in both early and late-stage tumors, suggesting it happens early in cancer development.
Long-term adult cancer survivors face a higher risk of experiencing serious psychological distress due to effects on physical health and social adaptation. Approximately 5.6% of cancer survivors screened positive for severe psychological distress within the previous 30 days.
A major study published in The Lancet found that surgery after chemotherapy and radiation can prolong survival without progression of the lung cancer, but does not improve overall survival compared to conventional treatment alone. Patients who underwent a section of the lung removal saw a major benefit from surgery.
A new trial shows that chemotherapy plus radiotherapy, either with or without surgery, are viable options for patients with stage IIIA (N2) non-small-cell lung cancer. The treatment improved overall survival and progression-free survival rates compared to standard concurrent chemotherapy and radiotherapy alone.
A new study published in the International Journal of Cancer found that women who experienced non-natural menopause are at almost twice the risk of developing lung cancer compared to women who experienced natural menopause. The increased risk was particularly observed among women who had both their ovaries surgically removed.
UT Southwestern Medical Center researchers have received a $2 million grant to study lung cancer in nonsmokers. They will use a coordinated approach to discover biomarkers and develop a test to detect early-stage lung cancer.
Researchers found groundwater manganese positively associated with total cancer, colon cancer, and lung cancer death rates, while airborne manganese concentrations inversely associated with these cancers. Manganese exposure may worsen cancer rates due to increasing environmental levels.
Researchers found African Americans have lower survival rates for breast, prostate, and ovarian cancers due to biological factors, not socioeconomic ones. The study of 19,457 patients showed 49% more likelihood of death from early-stage breast cancer among African Americans.
Lung cancer's rapid spread is linked to a hyperactive WNT cell-signaling pathway, enabling aggressive tumor growth and poor clinical outcomes. The study identifies two genes activated by WNT that enhance invasion and reinitiation of tumor growth in other organs.
A study published in the Journal of Thoracic Oncology found a significant difference in the quality and type of lung cancer information available online in the US and Japan. The US websites were more likely to discuss standard treatment methods and had stricter ethical policies.
Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a unique model to isolate and study lung cancer stem cells. The model uses patient specimens and autologous tumor microenvironments to identify markers associated with cancer stem cells, providing proof-of-concept for the existence of these cells in lung cancer.
A new lung cancer therapy employing a vaporized viral vector to deliver a cancer-inhibiting molecule directly to lung tissue shows early promise in mouse trials. The delivery of genes via aerosol holds promise for the treatment of a broad spectrum of pulmonary disorders.
Researchers discovered that a nicotine receptor inhibitor, α-CbT, can double survival time in non-small cell lung carcinoma mice. The treatment showed significant antitumor activity by inducing apoptosis and had limited toxic effects on unaffected cells.
A study found that older age, lower education levels and longer smoking history are associated with a positive lung cancer diagnosis after an abnormal screening chest radiograph. A family history of lung cancer and suspicious masses also contribute to a true positive diagnosis.
A Phase III trial found that vandetanib significantly improved progression-free survival compared to chemotherapy alone. The therapy, which targets both EGFR and VEGFR, also showed reduced side effects, particularly nausea and vomiting.
A new study finds that exposure to particulate matter can reprogram genes associated with tumor suppression, affecting cancer development and outcomes. The changes are detectable after just three days of exposure, raising hopes for early interventions to prevent or reverse gene programming.
A Canadian Cancer Society-funded study will investigate the risk of bladder and kidney cancer associated with environmental exposure to arsenic in drinking water. Dr Louise Parker's three-year research project aims to help policy-makers decide whether new approaches to water testing and treatment are needed.
Researchers are launching a multi-institutional effort to develop a test to detect early-stage lung cancer in lifetime nonsmokers. The project aims to create a better understanding of the biology of lung cancer and identify potential biomarkers.
Researchers found that exercise programs significantly reduced lung cancer symptoms in patients who completed the study, with no deterioration in functional capacity or muscle strength. The study suggests that community-based or shorter exercise programs may be more feasible for lung cancer patients to complete.
A study found that patients diagnosed with lung cancer through CT scans had a significantly higher 5-year survival rate (91.2%) compared to those diagnosed with x-rays (77.8%). The study suggests that early detection of the disease using CT scans improves patient prognosis.
Researchers found women tend to be younger when developing lung cancer, despite smoking less than men, increasing the risk of tobacco carcinogens. Women's awareness of other cancers like breast cancer may also contribute to their vulnerability, with median survival after surgery being longer for women.
Researchers discuss personalized treatment options for early-stage lung cancer, using targeted therapies and cancer vaccines. A gene signature is being used to predict which patients will benefit from an immune-boosting vaccine designed to target MAGE-A3 protein.
Researchers present new techniques for early diagnosis and treatment of lung cancer, improving 5-year survival rates from 10% to 70%. A new factor that correlates with clinical parameters may also help indicate patient prognosis.
A phase III study found that adding cetuximab to standard chemotherapy for non-small-cell lung cancer (NSCLC) extends survival by almost one month compared to chemotherapy alone. The treatment has been shown to target epidermal growth factor receptor, which plays a key role in tumour growth.
A large prospective case-cohort study found no association between dietary acrylamide intake and lung cancer risk in men, but suggested an inverse association in women. The researchers hypothesize that acrylamide may affect hormonal balances to explain the findings.
Researchers are exploring new treatments for lung cancer using targeted therapies and personalized care. Studies have shown promising results in improving patient outcomes, including the use of molecular targeted therapies and chemotherapy combinations.
Notch1 contributes to lung fibrosis by increasing myofibroblasts, while SOCS-1 inhibits prostate cancer growth. TIP30 prevents lung cancer metastasis, and SPARC accelerates kidney disease progression. These findings highlight potential new therapeutic targets.
A new report reveals a significant increase in the number of people diagnosed with cancer in Ireland, but also shows that survival rates are rising for certain types of cancer. The report highlights the importance of prevention and early detection in reducing the burden of cancer.
A computer-aided detection system has been shown to detect 45-55% of overlooked lung cancer nodules, potentially leading to earlier diagnosis and improved survival rates. The study suggests that CAD software can assist radiologists in identifying subtle signs of early lung cancer.
Human lung tumors can destroy Vitamin D, a hormone with anti-cancer properties, according to a new study. The researchers developed a test to measure Vitamin D levels in tissues and blood, which could help identify the best approaches to maintain therapeutic levels of Vitamin D.
Researchers at Washington University School of Medicine have uncovered the genetic source of pleuropulmonary blastoma (PPB), a rare and aggressive childhood lung cancer. The study found that some children with PPB are born with deleterious mutations in the DICER1 gene, which is involved in regulating gene expression.
Researchers found that a urine metabolite called NNAL predicts risk of lung cancer in smokers, with higher levels associated with increased risk. The study, published by the American Association for Cancer Research, analyzed data from over 50,000 patients.
Scientists at the University of Cincinnati have identified the RGS17 gene as a major suspect in familial lung cancers. Further investigation may lead to genetic testing for high-risk patients, enabling early detection and treatment.
A study found that black patients with non-small cell lung cancer are 37% less likely to receive recommended surgery and 42% less likely to receive recommended chemotherapy than white patients. The disparity remains despite efforts to address inequalities in medical treatment.
A new study by researchers at the University of Michigan Comprehensive Cancer Center found that higher doses of radiation combined with chemotherapy improve survival in patients with stage III lung cancer. Concurrent chemotherapy increases treatment effectiveness and overall survival rates.
A retrospective analysis found that multiple lung tumors in patients often arise from a single cancer cell, suggesting multifocal lung cancers should be classified as advanced-stage cancers. The study analyzed 70 tumor samples and concluded that 77% of patients had multiple tumors originating from a single clone.
A large cohort study found that long-term survivors of hereditary retinoblastoma are at a significantly increased risk of death due to subsequent cancers. Hereditary retinoblastoma survivors had a 35-fold higher mortality rate compared to the general population.
Researchers at UVA Health System found that SRC gene promotes growth suppression in bladder cancer, contradicting its role in most cancers. The study suggests caution when using targeted therapeutic agents that inhibit SRC in bladder cancer treatment.
Researchers found that cetuximab's success in treating non-small cell lung cancer depends on the production of a specific protein called u-PAR. Higher levels of u-PAR indicate reduced responsiveness to the treatment, suggesting it could be used as a biomarker.
A new technique called stereotactic body radiotherapy (SBRT) has been shown to significantly improve survival rates for early-stage lung cancer patients, with a median survival range of over 32 months. The treatment doubles the odds of surviving and can even cure at least half of the patients, offering hope without the need for surgery.
A recent study found that socioeconomic status is linked to an increased risk of developing lung cancer, with Europeans having lower education levels experiencing a higher incidence. The research suggests that while smoking accounts for approximately half of this risk, diet and other factors also play a role in the disparity.
Researchers at Wake Forest University have developed a new class of platinum-based anti-tumor drugs that demonstrate 10 times greater efficacy than current treatments against certain lung cancer types. The compounds work by rapidly binding with and disabling tumor cell DNA, potentially overcoming drug resistance issues.
Survivors of early-stage lung cancer who engage in regular physical activity experience improved mood, vigor, and physical functioning. Moderate exercise, such as brisk walking a few times a week, may promote better quality of life and reduce depressive symptoms.
The 2009 awards recognize groundbreaking work in early detection of ovarian and lung cancers, improvements to bone marrow transplant safety, and discovery of new genetic markers for cancer. The $450,000 prize will support the projects over three years.
A recent UC Davis study found that smoking is linked to over 70% of cancer death burden among Massachusetts men in 2003, surpassing previous estimates. The study suggests that increased tobacco control efforts could save more lives and improve health outcomes.
A study examines racial disparities in survival among black patients diagnosed with early-stage lung cancer. Despite recommended treatment, black patients have lower five-year survival rates compared to white patients.
The National Lung Cancer Partnership and LUNGevity Foundation have awarded $100,000 research grants to Prasad Adusumilli and Lee Goodglick. Dr. Adusumilli's study will investigate visceral pleural invasion, while Dr. Goodglick's research focuses on estrogen's role in lung cancer.
National Lung Cancer Partnership awards I-Ching Wang a Career Development Award to study FoxM1, a protein linked to aggressive lung cancer growth. The grant aims to support protein-directed therapies and control the leading US cancer killer. Dr. Wang's research will help combat underfunding in federal lung cancer research.
A recent study by Boston University researchers has identified a class of microRNAs that regulate gene expression changes in airway cells caused by smoking and lung cancer. These findings may lead to a non-invasive biomarker for smoking-related lung diseases, improving early diagnosis and treatment options.
Researchers at the University of Cincinnati have identified a new tumor suppressor, protein kinase C-zeta, that may help develop targeted drug therapies to combat lung cancer. The study found that PKC-zeta normally slows down Ras transformation and prevents tumor development, but its absence or inactivity accelerates cancer growth.